Assertio (ASRT)
(Delayed Data from NSDQ)
$0.84 USD
+0.01 (0.85%)
Updated Oct 13, 2025 04:00 PM ET
After-Market: $0.84 0.00 (-0.25%) 6:20 PM ET
5-Strong Sell of 5 5
B Value C Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ASRT 0.84 +0.01(0.85%)
Will ASRT be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ASRT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ASRT
New Strong Sell Stocks for September 23rd
New Strong Sell Stocks for September 19th
ASRT: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for September 16th
New Strong Sell Stocks for August 26th
Assertio (ASRT) Reports Q2 Loss, Beats Revenue Estimates
Other News for ASRT
50 Day Moving Average Support appears for ASRT after 4.56% move
ASRT forms 20 Day Moving Average Resistance on October 9
Assertio Therapeutics Amends ROLVEDON Supply Agreement
Is ASRT signaling a buying opportunity? 1,2,3 Pullback Bullish shows up after rising 0.21%
ASRT forms 1,2,3 Pullback Bullish on October 7